Timeline

14 Feb 2023

publication

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

27 Aug 2022

publication

IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies.

04 Jul 2022

publication

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

15 Mar 2022

publication

Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.

15 Dec 2021

publication

SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.

01 Nov 2021

publication

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.

17 Sep 2021

publication

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.

01 Sep 2021

publication

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

18 Aug 2021

news

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

01 Aug 2021

publication

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

11 May 2021

publication

Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients.

15 Apr 2021

publication

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.

01 Jan 2021

publication

Characteristics Associated with Olfactory and Taste Disorders in COVID-19.

01 Sep 2020

publication

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

01 Mar 2020

publication

Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses.

05 Feb 2020

publication

Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.

18 Feb 2019

publication

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses.

27 Jun 2018

publication

Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection.

A little guide for advanced search:

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.

IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies.

Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.

Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.

SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.

Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.

Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.

Immune checkpoint inhibitors improve cellular immunity against SARS-CoV-2 infection

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients.

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.

Characteristics Associated with Olfactory and Taste Disorders in COVID-19.

Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses.

Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses.

Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection.